Fyremadel 250 ug/.5mL
ganirelix acetate · INJECTION, SOLUTION · Ferring Pharmaceuticals Inc.
Fyremadel is a injection, solution containing ganirelix acetate at 250 ug/.5mL, taken subcutaneous. Manufactured by Ferring Pharmaceuticals Inc..
Key Facts
- Brand Name
- Fyremadel
- Generic Name
- ganirelix acetate
- NDC Code (Product)
55566-1010- Manufacturer
- Ferring Pharmaceuticals Inc.
- Strength
- 250 ug/.5mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- ANDA204246
- Marketing Start
- 02/28/2022
Recall History
No Recall HistoryFrequently Asked Questions
What is Fyremadel used for?
Fyremadel contains ganirelix acetate. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Fyremadel a controlled substance?
Fyremadel is not classified as a controlled substance by the DEA.
What is the generic name for Fyremadel?
The generic name for Fyremadel is ganirelix acetate. There are 9 other brand versions of ganirelix acetate.
What is the NDC code for Fyremadel 250 ug/.5mL?
The NDC (National Drug Code) for Fyremadel 250 ug/.5mL is 55566-1010, listed by Ferring Pharmaceuticals Inc..
Other Ganirelix Brands
See all →- Ganirelix Acetate250 ug/.5mL70748-274
- Ganirelix Acetate250 ug/.5mL78206-138
- Ganirelix Acetate250 ug/.5mL71288-554
- Ganirelix Acetate250 ug/.5mL65219-028
- Ganirelix Acetate250 ug/.5mL67184-0574
- Ganirelix Acetate250 ug/.5mL0548-5001
- Ganirelix Acetate250 ug/.5mL70700-327
- Ganirelix Acetate250 ug/.5mL83301-0082
- GANIRELIX ACETATE250 ug/.5mL68083-472
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)